Migros, a retail company, completed the acquisition of the Swiss business of Zur Rose Group, an online pharmacy and pharma wholesaling company, for $396m. “With a clear focus on our B2C core business we will put patients and customers even more at the centre. In addition, this transaction will further strengthen our excellent position for the upcoming e-prescription rollout in Germany. At the same time, Migros is the ideal future owner for all our employees in Switzerland, under which Zur Rose can continue to develop successfully,” Walter Hess, Zur Rose Group CEO.